Crossmark

Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death

Published Online: 2019-12-17

Published Print: 2019-12

Authors

Yokokawa, Tetsuro https://orcid.org/0000-0001-8197-3274
Ichimura, Shohei

Hijioka, Naoko

Kaneshiro, Takashi

Yoshihisa, Akiomi

Kunii, Hiroyuki

Nakazato, Kazuhiko

Ishida, Takafumi

Suzuki, Osamu

Ohno, Seiko

Aiba, Takeshi

Ohtani, Hiroshi

Takeishi, Yasuchika
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-17
More Information

Article History

Received: 24 January 2019

Accepted: 27 November 2019

First Online: 17 December 2019

Ethics approval and consent to participate

: This study was approved by Fukushima Medical University Hospital and the National Cerebral and Cardiovascular Center. Written informed consent was provided by the patients.

: Written informed consent for publication was obtained from the patients.

: Tetsuro Yokokawa belongs to a department supported by Actelion Pharmaceuticals Japan. Takashi Kaneshiro belongs to a department supported by Biotronic Japan and Abbot Japan. Akiomi Yoshihisa belongs to a department supported by Fukuda Denshi Co. Ltd. These companies were not associated with the contents of this study.

Document is current